Telemonitoring in Coronary Artery Disease
Conditions
Keywords
Telemonitoring, Chronic Heart Failure, eHealth, Mortality
Brief summary
TEMA-HF 1 Long-Term Follow-up study is a follow-up study of TEMA-HF 1. It assessed the long-term impact of a 6-months telemonitoring program in chronic heart failure patients.
Detailed description
The telemonitoring (TM) group patients received a 6-months TM program, followed by standard heart failure care until the long-term follow-up evaluation. The usual care (UC) patients received ususal care during the first six months, followed by standard heart failure care until the long-term follow-up evaluation.
Interventions
OTHERTelemonitoring
Sponsors
Hasselt University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Intervention model description
Prospective, multi-center randomized controlled trial
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Chronic heart failure patients * Treated for heart failure according to current guidelines * ≥ 18 years of age * Able to provide informed consent
Exclusion criteria
* Reversible forms of acute heart failure (myocarditis) * Presence of severe aortic stenosis * Previous residency in a nursing home * Inclusion in a cardiac rehabilitation program on discharge * Chronic kidney disease stage ≥ 4 * Planned dialysis in the next six months * Life expectancy \< 1 year due to non-heart failure related reasons * Severe chronic obstructive pulmonary disease, GOLD ≥ III * Cognitive and/or mental problems interfering with the performance of daily measurements and data transmission
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All-cause mortality | Start of study to long-term follow-up (6.5 years). | All-cause mortality |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| days lost due to all readmissions | Start of study to long-term follow-up (6.5 years). | days lost due to all readmissions |
| days lost due to death or heart failure readmissions | Start of study to long-term follow-up (6.5 years). | days lost due to death or heart failure readmissions |
| days lost due to heart failure readmissions | Start of study to long-term follow-up (6.5 years). | days lost due to heart failure readmissions |
| percentage of follow-up time spent in hospital for all reasons | Start of study to long-term follow-up (6.5 years). | percentage of follow-up time spent in hospital for all reasons |
| percentage of follow-up time lost to death or heart failure readmissions | Start of study to long-term follow-up (6.5 years). | percentage of follow-up time lost to death or heart failure readmissions |
| percentage of follow-up time spent in hospital for heart failure | Start of study to long-term follow-up (6.5 years). | percentage of follow-up time spent in hospital for heart failure |
Outcome results
None listed